0XU44KZ
Supplement Axilla, Right to No Qualifier with Nonautologous Tissue Substitute, Percutaneous Endoscopic Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | X Anatomical Regions, Upper Extremities |
| Operation | U Supplement |
| Body Part | 4 Axilla, Right |
| Approach | 4 Percutaneous Endoscopic |
| Device | K Nonautologous Tissue Substitute |
| Qualifier | Z No Qualifier |
Operation Definition
Putting in or on biological or synthetic material that physically reinforces and/or augments the function of a portion of a body part
Procedure Overview
Supplement procedures put in biological or synthetic material to reinforce or augment an upper extremity structure that remains in place, rather than replacing it outright. A typical scenario is applying a mesh or patch graft over an area of weakened soft tissue or fascia in the arm to strengthen it, or augmenting a regional defect with additional material while the native anatomy stays where it is.
This approach is chosen when the existing tissue is intact enough to remain functional but needs added support, commonly after trauma, chronic strain, or a structural weakness identified during another procedure. It differs from a from-scratch repair because material is physically added to bolster the area, and it differs from a full swap because nothing is being removed and replaced.
Anatomy & Axis Detail
Axilla, Right
The right axilla, the soft tissue region beneath the junction of the arm and chest wall, is a Supplement site when material is added to reinforce or fill a defect in this area, most often after lymph node dissection, tumor excision, or reconstructive surgery leaves a soft tissue gap. Because the axilla contains a dense network of vessels, nerves, and lymphatics passing to the upper extremity, any supplemental material placed here is typically limited to superficial soft tissue augmentation rather than structural support, distinguishing it from procedures on the deeper neurovascular contents. Documentation should identify the type of graft or synthetic material used and confirm that native axillary tissue was reinforced in place rather than excised and substituted, which would instead be coded as replacement.
Approach: Percutaneous Endoscopic
Percutaneous Endoscopic combines a puncture through skin or mucous membrane with insertion of an endoscope to visualize the procedure internally, as in laparoscopic cholecystectomy. It is distinguished from plain Percutaneous by the presence of scope-guided visualization, and from Via Natural or Artificial Opening Endoscopic by its route being a new puncture rather than an existing orifice or stoma.
Device: Nonautologous Tissue Substitute
Nonautologous Tissue Substitute refers to biologic material sourced from a donor or another species, such as an allograft or xenograft, used to replace a body part. It differs from Autologous Tissue Substitute by tissue origin outside the patient's own body, and from Synthetic Substitute by being biologic rather than manufactured material.
Coding & Documentation
Coders assign a code from this family when the operative note documents that graft, mesh, or synthetic material was placed onto or into an existing upper extremity structure purely to reinforce or augment it, with the native tissue left intact, and the documentation should specify the material type and the exact regional location covered. A common error is coding Supplement when the surgeon actually excised damaged tissue first and put in a substitute, which belongs under Replacement instead. Another recurring issue is failing to capture whether the reinforcing material is autologous, nonautologous, or synthetic, since this qualifier changes the specific code and is easy to overlook if the operative note only says "graft placed" without further detail.